PATENT CLAIM ANALYSIS

Application Number: 16107605
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-02
Patent Classification: ["514", "293000"]

Abstract:
Disclosed are alkyl chain modified 1H-imidazoquinoline compounds, derivatives and analogs thereof, as Toll-like receptor-7 and -8 agonists for enhancing immune responses. Also provided are methods of making pharmaceutical compositions containing these compounds. The present disclosure also describes methods of use for the alkyl chain modified 1H-imidazoquinoline compounds, derivatives and analogs thereof, and pharmaceutical compositions containing these compounds for the treatment of disease in a subject.

Claim (Index 46):
A method of treating cancer in a mammalian subject in need thereof, comprising administering to the mammalian subject the pharmaceutical composition of  claim 35  in an amount sufficient to treat cancer in the mammalian subject.

Metadata:
- Claim Count in Document: 54.0
- Percentile: 96.0
- Lexical Diversity: 1.67442
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15848349', '13475284', '14279416', '15793820', '13832179']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.789572677554728
- 35 USC 102 Novelty (BERT): 0.5278100709847146
- Combined Prediction Score: 0.7633964168977267
- Mean Citation Score: 308.7829920000001
- Max Citation Score: 313.4957
- Similarity Product: 150.19128312415484

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test